Welcome
Actavis received two warnings because of “adulterated” drugs
May 21st, 2008
In the wake of the Digitek recall, reports have emerged that Actavis Totowa, the manufacturer of the heart drug, received two warning letters from the Food and Drug Administration in 2006 and 2007. The letters charged the company with failing to properly report adverse events for drugs including Digitek and for failing to follow “Good [...]